Medpace Holdings (MEDP) Current Deferred Revenue (2015 - 2026)

Medpace Holdings (MEDP) has reported Current Deferred Revenue for 12 consecutive years, with $856.3 million the latest figure, recorded in Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $856.3 million, up 19.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $856.3 million (up 19.15% YoY), and the FY2025 annual result was $854.4 million, up 20.24% from the prior year.
• Current Deferred Revenue was $856.3 million for Q1 2026 at Medpace Holdings, roughly flat from $854.4 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $856.3 million in Q1 2026 and troughed at $367.2 million in Q1 2022.
• Average Current Deferred Revenue over 5 years is $611.4 million, with a median of $616.7 million recorded in 2024.
• Year-over-year, Current Deferred Revenue surged 42.22% in 2022 and advanced 16.54% in 2025.
• Over 5 years, Current Deferred Revenue stood at $462.7 million in 2022, then climbed by 20.99% to $559.9 million in 2023, then climbed by 26.92% to $710.6 million in 2024, then grew by 20.24% to $854.4 million in 2025, then gained by 0.23% to $856.3 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $856.3 million in Q1 2026, $854.4 million in Q4 2025, and $834.3 million in Q3 2025.